- Home
- VICR vs AAPG Comparison
VICR vs AAPG Comparison
Compare VICR & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VICR
- AAPG
- Stock Information
- Founded
- VICR 1981
- AAPG 2009
- Country
- VICR United States
- AAPG China
- Employees
- VICR N/A
- AAPG N/A
- Industry
- VICR Industrial Machinery/Components
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- VICR Technology
- AAPG Health Care
- Exchange
- VICR Nasdaq
- AAPG Nasdaq
- Market Cap
- VICR 4.1B
- AAPG 3.6B
- IPO Year
- VICR N/A
- AAPG 2025
- Fundamental
- Price
- VICR $93.10
- AAPG $32.70
- Analyst Decision
- VICR Buy
- AAPG Strong Buy
- Analyst Count
- VICR 2
- AAPG 3
- Target Price
- VICR $90.00
- AAPG $49.00
- AVG Volume (30 Days)
- VICR 715.0K
- AAPG 8.2K
- Earning Date
- VICR 10-21-2025
- AAPG 11-19-2025
- Dividend Yield
- VICR N/A
- AAPG N/A
- EPS Growth
- VICR 1696.11
- AAPG N/A
- EPS
- VICR 1.81
- AAPG N/A
- Revenue
- VICR $441,603,000.00
- AAPG $54,524,554.00
- Revenue This Year
- VICR $28.39
- AAPG N/A
- Revenue Next Year
- VICR $3.64
- AAPG $368.64
- P/E Ratio
- VICR $51.17
- AAPG N/A
- Revenue Growth
- VICR 24.20
- AAPG N/A
- 52 Week Low
- VICR $38.93
- AAPG $16.50
- 52 Week High
- VICR $96.58
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- VICR 68.07
- AAPG 39.48
- Support Level
- VICR $81.92
- AAPG $31.01
- Resistance Level
- VICR $94.42
- AAPG $34.31
- Average True Range (ATR)
- VICR 5.04
- AAPG 0.81
- MACD
- VICR -0.42
- AAPG 0.03
- Stochastic Oscillator
- VICR 77.83
- AAPG 42.75
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.